Ownership and Access in Scholarly Publishing
| Home | Program | Keynote Speakers | Panelists | Webcast |
Emerging Issues in Scientific Publishing
Kenneth R. Fulton,
Executive Director, National Academy of Sciences
Kenneth R. Fulton is the Executive Director of the National Academy of Sciences. Following service in the U.S. Navy, where he was trained as a linguist, he joined the staff of the Academy in 1971. He served as administrative officer for the Office of Scientific Personnel, and then as program officer in the Food and Nutrition Board, coordinating several studies of the use and consumption of food additives for the Food and Drug Administration. In this capacity, he served for three years on the U.S. delegation to the Codex Alimentarius Commission of the United Nations. In 1980, he was appointed to the Academy's executive office, first as director of membership, then as special assistant to the president, and finally as executive director.
Mr. Fulton manages the Academy's membership and program activities, including the election of members and their annual and regional meetings; the offices of the Academy president and vice president and its governing Council; the National Academies Keck Futures Initiative; the Arthur M. Sackler colloquia and Frontiers of Science symposia; the Marian E. Koshland Science Museum; and the Office of Exhibitions and Cultural Programs, which brings art exhibits and concerts to the Washington community. He is also the publisher of the Proceedings, the Academy's journal of original research.
Mr. Fulton holds a bachelor's degree in the social and behavioral sciences, and a masters degree in management. He is a member of the American Society of Association Executives, the American Association for the Advancement of Science, and the Society for Scholarly Publishing. He serves on the Committee on Dissemination of Scientific Information of the International Council for Science. He is listed in Who’s Who in America, and Who’s Who in the East.
John Wilbanks,
Executive Director, Science Commons
John Wilbanks serves as Executive Director of Science Commons, a project created to facilitate sharing scientific information as a means to improve scientific innovation. He has spent much time working in the intersections of law, technology and science. Mr. Wilbanks formerly worked as the first assistant director of the Berkman Center for Internet and Society at Harvard Law School, where he led software development and internet-mediated learning. He also founded and led to acquisition Incellico, a bioinformatics company that built semantic graph networks for use in pharmaceutical discovery. He has served as a Fellow at the World Wide Web Consortium in Semantic Web for Life Sciences.
The Science Commons investigates means for licensing scientific property, data and knowledge via an open access model. By this means, authors will work with a neutral third-party public interest group and retain control over their works in terms of attribution, commercialization, derivative works and re-distribution. The Science Commons plans to address issues particular to publishing peer-reviewed scientific material, such electronic archiving and pre- and post-print licensing. Not only is the project looking into alternative models for licensing, but also new technologies that facilitate its implementation.
Valuing New Models of Scholarship in Promotion and Tenure
Marian Jackson, Ph.D.,
Acting Vice President for Academic Affairs,
Associate Professor Medical Biotechnology Center
University of Maryland Biotechnology Institute
Marian Jackson is Associate Vice President for Academic Affairs, University of Maryland Biotechnology Institute (UMBI) and Associate Professor, UMBI and Department of Neurology, University of Maryland, Baltimore. She studies the genetic control of development and differentiation. In particular, she investigates the synthesis of arginine, an essential amino acid, and the genetic regulation of nitric oxide metabolism. Dr. Jackson also researches genes whose expression may play a part in moderating the development of mammary tumors.
In addition to her research, Dr. Jackson has served the University of Maryland as chair of the faculty staff senate at the Biotechnology Institute. As leader of this group, she worked on projects involving research and intellectual property.
Sharon Krag, Ph.D.,
Professor Biochemistry and Molecular Biology; Associate Dean, Graduate Education and Research, Johns Hopkins Bloomberg School of Public Health
Dr. Krag received a B.S. in chemistry and biology from Texas Lutheran College, received her Ph.D. in biochemistry from Johns Hopkins University, and completed postdoctoral work at the Center for Cancer Research at Massachusetts Institute of Technology.
She is currently a professor in Biochemistry and Molecular Biology and the Associate Dean for Graduate Education and Research. Her research focuses on lipid intermediates in N-linked glycosylation, an important process in cell-surface interactions. She teaches a required course in responsible conduct of research and a course in Molecular Biology of Disease at the Bloomberg School of Public Health.